An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.
Several experts said the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Material Removal
According to TikTok, the service has removed problematic material and prohibited related keywords and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, positive reviews and detailed instructions for preparing or administering at home.
After moments of entering one group, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Item Details and Costs
Within these communities, messages display black plastic parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has already encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious medical dangers”.
